Comparison Chart Newron Pharmaceuticals S.p.A.
Stocks
NWRN
IT0004147952
Biotechnology & Medical Research
|
Market Closed -
Swiss Exchange
16:30:23 20/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 8.190 CHF | -4.32% |
|
-5.32% | -65.66% |
| 10-22 | Newron Pharmaceuticals S.p.A. Completes Enrollment In Pivotal Phase 3 ENIGMA-TRS 1 Study | CI |
| 10-22 | Newron Pharmaceuticals Completes Enrollment for Schizophrenia Drug Late-stage Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Other Biotechnology & Medical Research | -4.32% | -5.32% | -65.66% | -46.54% | +342.22% | 207M |
- Stock Market
- Stocks
- NWRN Stock
- Charts Newron Pharmaceuticals S.p.A.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















